Teva Pharmaceutical Industries (TEVA) EBIT Margin Growth (3y) (2019 - 2026)
Teva Pharmaceutical Industries (TEVA) EBIT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn | 13,036.00 |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn | 5,091.00 |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn | -11,841.00 |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn | 2,466.00 |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn | -698.00 |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn | 25,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,673.00 |
| Dec 31, 2025 | 3,057.00 |
| Sep 30, 2025 | 789.00 |
| Jun 30, 2025 | 3,644.00 |
| Mar 31, 2025 | 3,281.00 |
| Dec 31, 2024 | -290.00 |
| Sep 30, 2024 | -1,721.00 |
| Jun 30, 2024 | -1,500.00 |
| Mar 31, 2024 | -1,661.00 |
| Dec 31, 2023 | 785.00 |
| Sep 30, 2023 | 11,809.00 |
| Jun 30, 2023 | -2,133.00 |
| Mar 31, 2023 | -474.00 |
| Dec 31, 2022 | -2,751.00 |
| Sep 30, 2022 | 1,377.00 |
| Jun 30, 2022 | -1,012.00 |
| Mar 31, 2022 | -2,271.00 |
| Dec 31, 2021 | 7,350.00 |
| Sep 30, 2021 | 1,566.00 |
| Jun 30, 2021 | 1,519.00 |